iCarbonX

iCarbonX is focused on creating a comprehensive ecosystem of digital health by integrating consumers' life data with artificial intelligence and biotechnology. The company, founded by a team with extensive experience in omics technology and data analysis from BGI Tech, aims to establish a leading data collection platform for health information in China. By gathering a wide range of data—including genomic, phenotypic, behavioral, social, and environmental factors—iCarbonX provides personalized health analyses and predictions. Its platform is designed to empower individuals to understand their genetic profiles and make informed decisions about their health and well-being, leveraging advanced data mining and machine learning techniques.

Hao Li

Co-Founder and CIO

Jun Wang

Founder and CEO

Cindy Yang

Partner / Chief Investment Officer

9 past transactions

Reach Media

Series B in 2018
Shanghai Reach Media Co., Ltd. is an advertising services provider founded in 2014 and headquartered in Shanghai, China. The company specializes in creating advertising opportunities within medium to high-end communities. Its services include advertising bulletin boards that focus on cultural community activities and service-oriented information channels. This approach allows businesses to effectively promote their products and services while enabling communities to share important news and updates with residents. Through these targeted advertising solutions, Reach Media aims to connect companies with a broader consumer base.

SomaLogic

Private Equity Round in 2018
SomaLogic, Inc. is a commercial-stage company based in Boulder, Colorado, specializing in protein biomarker discovery and clinical diagnostics. Founded in 1999, the company has developed advanced technologies such as SOMAmers, slow off-rate modified aptamers that specifically bind to target proteins, and the SOMAscan platform, which facilitates comprehensive protein measurement. This innovative approach allows for the analysis of protein biomarker signatures, significantly enhancing the understanding of health and disease beyond traditional genomic methods. SomaLogic's products are utilized in a variety of applications, including diagnostics for conditions in oncology, neurology, and cardiovascular and metabolic diseases, as well as in drug discovery and development. The company also offers diagnostic tests and protein measurement solutions for life science and biopharma researchers, contributing to advancements in medical science.

HealthLoop

Series B in 2017
HealthLoop, Inc. operates a software-as-a-service platform that supports medical practices in monitoring patient recovery through ongoing communication and symptom tracking. Founded in 2009 and based in Moffett Field, California, the platform enables healthcare providers to identify patients at risk of decline during the follow-up period. By collecting patient feedback and comparing their recovery status against expected progress, HealthLoop facilitates timely alerts to physicians regarding potential treatment failures, complications, or hospital readmissions. The company primarily serves medical offices across the United States, aiming to enhance patient engagement and improve overall care coordination.

PatientsLikeMe

Venture Round in 2017
PatientsLikeMe, Inc. operates a healthcare data-sharing platform that facilitates the exchange of symptoms, treatments, health data, and personal experiences among patients, caregivers, healthcare professionals, and researchers. Founded in 2004 and based in Cambridge, Massachusetts, the platform serves over 600,000 members and focuses on a broad range of health conditions, including cancer, mental health, and chronic diseases. PatientsLikeMe enables users to discover new treatment options, connect with peers, and engage in health management to enhance their outcomes. The company collaborates with major pharmaceutical firms and government organizations to incorporate patient insights into research, development, and public policy. Additionally, PatientsLikeMe has published over 100 research studies, establishing itself as a credible resource for real-world disease information. It is a subsidiary of United Healthcare Services, Inc.

PatientsLikeMe

Acquisition in 2017
PatientsLikeMe, Inc. operates a healthcare data-sharing platform that facilitates the exchange of symptoms, treatments, health data, and personal experiences among patients, caregivers, healthcare professionals, and researchers. Founded in 2004 and based in Cambridge, Massachusetts, the platform serves over 600,000 members and focuses on a broad range of health conditions, including cancer, mental health, and chronic diseases. PatientsLikeMe enables users to discover new treatment options, connect with peers, and engage in health management to enhance their outcomes. The company collaborates with major pharmaceutical firms and government organizations to incorporate patient insights into research, development, and public policy. Additionally, PatientsLikeMe has published over 100 research studies, establishing itself as a credible resource for real-world disease information. It is a subsidiary of United Healthcare Services, Inc.

AOBiome

Series C in 2017
AOBiome, LLC is a biotechnology company based in Cambridge, Massachusetts, specializing in the development of microbiome-based therapies for inflammatory skin conditions and other systemic health issues. The company focuses on restoring ammonia-oxidizing bacteria to improve skin health and has a diverse portfolio of clinical-stage programs. These include studies targeting acne vulgaris, pediatric and adult eczema, episodic migraines, and allergic rhinitis, along with preclinical initiatives for various inflammatory conditions. AOBiome also offers consumer products under the Mother Dirt brand that aim to restore the skin biome. Founded in 2012 and initially known as NitroCell BioSciences LLC, AOBiome has positioned itself at the intersection of biotechnology and consumer health, emphasizing the importance of the microbiome in overall well-being.

Banruo Computer

Post in 2016
Banruo Computer is assisted at research and development with computing. They were committed to providing big data computing services and application solutions in the internet, telecommunications, and financial industries. They have obtained property protection through the use of software copyrights and invention patents for their big data ETL processing, mathematical modelling, and computing simulation skills, as well as a variety of technologies.

Imagu Vision Technologies

Acquisition in 2016
Imagu Vision Technologies Ltd. specializes in developing software for object recognition in digital images and videos, utilizing advanced shape-based detection technology for geometric and topological analysis. Their solutions are tailored for various sectors, including healthcare, medical imaging, semiconductors, homeland security, and e-commerce, addressing specific challenges in each field. The company's technology excels in applications such as defect detection in e-commerce images, human object detection in military contexts, and segmentation of retinal blood vessels for medical analysis. Founded in 2005 and based in Tel-Aviv, Israel, Imagu Vision Technologies aims to enable machines to comprehend their surroundings, providing high-performance solutions that meet diverse customer requirements efficiently.

nongfadai.com

Series A in 2016
Nongfadai.com is a financial services platform for the agricultural supply chain. Their services for agriculture, rural areas, farmers, and meeting the funding gap in the development of modern agriculture.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.